ELVN has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Insider Trading Summary & Commentary
Automated executive transaction analysis for ELVN
Over the last 90 days, corporate insiders at ELVN (ELVN) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 56 were sales. The total volume of insider trading reached $78.56M.
The net insider activity for ELVN shows a net selling bias of $78.56M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Orbimed Advisors LLC (10%), who traded 860.1K shares valued at $39.01M on Jun 22, 2026.
Live Market News & Developments
Aggregated real-time headlines for ELVN (ELVN)
6 updates
ELVN Stock On Track For Best Week Since March Following FDA-Aligned Path For Cancer Drug Development
Yahoo Finance160d ago
Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
PR Newswire161d ago
ELVN - Enliven Therapeutics Inc Stock Price and Quote
Finviz177d ago
$884.4 million in cash and securities is expected to fund Enliven into 2030 as its leukemia trial stays on track for 2026.
Stock Titan14d ago
Why is Enliven Therapeutics (ELVN) One of the Best Performing Healthcare Stocks so Far in 2026?
Yahoo Finance193d ago
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
PR Newswire157d ago
FAQs About ELVN Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ELVN.
Based on SEC Form 4 disclosures, the Insider Confidence Score for ELVN is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 56 sales by company executives over the last 90 days.
The CEO Conviction Index for ELVN is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.